Stay updated on Atrasentan in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Atrasentan in IgA Nephropathy Clinical Trial page.
Latest updates to the Atrasentan in IgA Nephropathy Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the page, with no changes to the study details or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check18 days agoChange DetectedMinor metadata updates to the PubMed publications attribution and revision label in the study details (v3.3.1), replacing the previous PubMed attribution and revision (v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check25 days agoChange DetectedDeleted the government funding/operating status notice from the page, removing a generic informational banner. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check39 days agoChange DetectedThe changes appear to be minor UI/layout adjustments between versions, with no alterations to core study details or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check69 days agoChange DetectedUpdated the revision label from v3.0.2 to v3.2.0, indicating a newer version has been released. No other content changes observed.SummaryDifference0.1%
- Check70 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0, with no other content changes.SummaryDifference0.1%
Stay in the know with updates to Atrasentan in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atrasentan in IgA Nephropathy Clinical Trial page.